BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25246577)

  • 21. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma.
    Lindberg N; Kastemar M; Olofsson T; Smits A; Uhrbom L
    Oncogene; 2009 Jun; 28(23):2266-75. PubMed ID: 19421151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribosome profiling reveals a cell-type-specific translational landscape in brain tumors.
    Gonzalez C; Sims JS; Hornstein N; Mela A; Garcia F; Lei L; Gass DA; Amendolara B; Bruce JN; Canoll P; Sims PA
    J Neurosci; 2014 Aug; 34(33):10924-36. PubMed ID: 25122893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine.
    Roos WP; Batista LF; Naumann SC; Wick W; Weller M; Menck CF; Kaina B
    Oncogene; 2007 Jan; 26(2):186-97. PubMed ID: 16819506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
    Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
    Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant gliomas can be converted to non‑proliferating glial cells by treatment with a combination of small molecules.
    Oh J; Kim Y; Baek D; Ha Y
    Oncol Rep; 2019 Jan; 41(1):361-368. PubMed ID: 30365111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells.
    Rani SB; Rathod SS; Karthik S; Kaur N; Muzumdar D; Shiras AS
    Neuro Oncol; 2013 Oct; 15(10):1302-16. PubMed ID: 23814265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligodendrocyte precursor cell-intrinsic effect of Rheb1 controls differentiation and mediates mTORC1-dependent myelination in brain.
    Zou Y; Jiang W; Wang J; Li Z; Zhang J; Bu J; Zou J; Zhou L; Yu S; Cui Y; Yang W; Luo L; Lu QR; Liu Y; Chen M; Worley PF; Xiao B
    J Neurosci; 2014 Nov; 34(47):15764-78. PubMed ID: 25411504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma.
    Lu F; Chen Y; Zhao C; Wang H; He D; Xu L; Wang J; He X; Deng Y; Lu EE; Liu X; Verma R; Bu H; Drissi R; Fouladi M; Stemmer-Rachamimov AO; Burns D; Xin M; Rubin JB; Bahassi EM; Canoll P; Holland EC; Lu QR
    Cancer Cell; 2016 May; 29(5):669-683. PubMed ID: 27165742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination.
    Li C; Xiao L; Liu X; Yang W; Shen W; Hu C; Yang G; He C
    Glia; 2013 May; 61(5):732-49. PubMed ID: 23440860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
    Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
    Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.
    Daginakatte GC; Gutmann DH
    Hum Mol Genet; 2007 May; 16(9):1098-112. PubMed ID: 17400655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
    Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asymmetry-defective oligodendrocyte progenitors are glioma precursors.
    Sugiarto S; Persson AI; Munoz EG; Waldhuber M; Lamagna C; Andor N; Hanecker P; Ayers-Ringler J; Phillips J; Siu J; Lim DA; Vandenberg S; Stallcup W; Berger MS; Bergers G; Weiss WA; Petritsch C
    Cancer Cell; 2011 Sep; 20(3):328-40. PubMed ID: 21907924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-of-origin susceptibility to glioblastoma formation declines with neural lineage restriction.
    Alcantara Llaguno S; Sun D; Pedraza AM; Vera E; Wang Z; Burns DK; Parada LF
    Nat Neurosci; 2019 Apr; 22(4):545-555. PubMed ID: 30778149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells.
    Kurtsdotter I; Topcic D; Karlén A; Singla B; Hagey DW; Bergsland M; Siesjö P; Nistér M; Carlson JW; Lefebvre V; Persson O; Holmberg J; Muhr J
    Cancer Res; 2017 Sep; 77(18):4985-4997. PubMed ID: 28687615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NMDA receptor couples Rac1-GEF Tiam1 to direct oligodendrocyte precursor cell migration.
    Xiao L; Hu C; Yang W; Guo D; Li C; Shen W; Liu X; Aijun H; Dan W; He C
    Glia; 2013 Dec; 61(12):2078-99. PubMed ID: 24123220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of p53 Concurrent with RAS and TERT Activation Induces Glioma Formation.
    Gong M; Fan X; Yu H; Niu W; Sun S; Wang H; Chen X
    Mol Neurobiol; 2023 Jun; 60(6):3452-3463. PubMed ID: 36867344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From the Cover: Neutralization of terminal differentiation in gliomagenesis.
    Hu J; Ho AL; Yuan L; Hu B; Hua S; Hwang SS; Zhang J; Hu T; Zheng H; Gan B; Wu G; Wang YA; Chin L; DePinho RA
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14520-7. PubMed ID: 23918370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanistic target of rapamycin pathway downregulates bone morphogenetic protein signaling to promote oligodendrocyte differentiation.
    Ornelas IM; Khandker L; Wahl SE; Hashimoto H; Macklin WB; Wood TL
    Glia; 2020 Jun; 68(6):1274-1290. PubMed ID: 31904150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chd7 Collaborates with Sox2 to Regulate Activation of Oligodendrocyte Precursor Cells after Spinal Cord Injury.
    Doi T; Ogata T; Yamauchi J; Sawada Y; Tanaka S; Nagao M
    J Neurosci; 2017 Oct; 37(43):10290-10309. PubMed ID: 28931573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.